Skip to main content
Fig. 7 | Cardiovascular Diabetology

Fig. 7

From: The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice

Fig. 7

Dasatinib inhibits BM adipogenesis in vitro. (A) ORO staining following induction of adipogenesis in the presence of Dasatinib or vehicle. (B) Dasatinib reduces the total number of human bone marrow pericytes and stromal cells. (C-D) Dasatinib reduces adipogenesis either considering the prevalence over total cells or the cell density per microscopic field. Bar graphs show means ± SEM and individual values. n = 4 biological replicates per group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840